ArticleNature communications2024

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.

Chandra Sekhar Amara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.